Skip to content
Screener

Aktis Oncology, Inc. AKTS Q3 2026 earnings

Reported November 12, 2026 · Before market open

Revenue$3.9MMiss by $968.5K
EPS-$0.54Miss by $0.07
Revenue estimate$4.9M
EPS estimate-$0.47

Next report

Date not yet announced

FAQ

When did Aktis Oncology, Inc. report Q3 2026 earnings?
Aktis Oncology, Inc. (AKTS) reported Q3 2026 earnings on November 12, 2026 before market open.
What were Aktis Oncology, Inc.'s Q3 2026 revenue and EPS?
Aktis Oncology, Inc. reported revenue of $3.9M and eps of $-0.54 for Q3 2026.
Did Aktis Oncology, Inc. beat estimates in Q3 2026?
Revenue missed the consensus estimate of $4.9M by $968.5K. EPS missed the consensus estimate of $-0.47 by $0.07.
Where can I find Aktis Oncology, Inc.'s Q3 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-457045) and the 10-Q periodic report (0001193125-26-457054) directly on SEC EDGAR. The filing index links above go to sec.gov.